BridgeMD
New treatment option for Hereditary Cancer Syndrome
Official title Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
ClinicalTrials.gov ID: NCT05664867
What this study is testing
- What it's testing
- The goal of this clinical trial is for researchers to compare the effectiveness of a mainstreamed model of genetic testing (MGT) with an enhanced standard of care model (SOC+) on the uptake of genetic testing among at-risk patients in an urban Federally Qualified Health Center (primary care) setting using a hybrid-effectiveness study design. Aim 1 is to compare the effectiveness of MGT and SOC+ interventions on the uptake of genetic testing among patients receiving primary care in an urban federally qualified health center (FQHC) system using a randomized trial study design.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older
You may be able to join if
- Aim 1 and 2 for patients
- Adults age 25+
- English speaking
- Identified as eligible for cancer genetic testing for a hereditary breast or colon cancer syndrome (e.g., BRCA, Lynch or familial polyposis syndrome)...
- Screened positive and agreed to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences...
You likely can't join if
- Did not meet the inclusion criteria
- Did not screen positive on HCRA and/ or did not agree to have study staff contact them in the future to participate in virtual/telephone interviews...
- Not a patient receiving care from the one of the clinics enrolled in the clincial trial Aim 2 Inclusion Criteria for Providers/Staff:
- Provider or staff member at one of the 4 clinics participating in the clinical trial
- English speaking Exclusion Criteria: 1\. Does not meet inclusion criteria above
See the full eligibility criteria
- Aim 1 and 2 for patients
- Adults age 25+
- English speaking
- Identified as eligible for cancer genetic testing for a hereditary breast or colon cancer syndrome (e.g., BRCA, Lynch or familial polyposis syndrome) as defined by NCCN criteria45-46
- Screened positive and agreed to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences with cancer genetics services.
- Patient receiving care from one of the 4 Federally Qualified Health Center clinics enrolled in the clinical trial
- Did not meet the inclusion criteria
- Did not screen positive on HCRA and/ or did not agree to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences with cancer genetics services.
- Not a patient receiving care from the one of the clinics enrolled in the clincial trial Aim 2 Inclusion Criteria for Providers/Staff:
- Provider or staff member at one of the 4 clinics participating in the clinical trial
- English speaking Exclusion Criteria: 1\. Does not meet inclusion criteria above
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.